CCB International
CCB International (Holdings) Limited, established in 1973, is an investment services firm based in Hong Kong and owned by China Construction Bank Corporation. The company operates across a comprehensive value chain that encompasses three primary segments: Pre-IPO, IPO, and Post-IPO services. CCB International offers a wide array of services, including underwriting, financial advisory, corporate mergers and acquisitions, restructuring, and refinancing for listed companies. Additionally, the firm engages in direct investment and asset management, alongside providing securities brokerage, market research, and investment consultancy. Through its subsidiaries, such as CCB International Capital and CCB International Asset Management, the firm delivers diverse investment solutions and services to meet the needs of its clientele.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Hong Kong
Hinova Pharma
Series C in 2020
Hinova Pharmaceuticals Inc. is a drug discovery and development company based in Chengdu, China, with additional branches in Hong Kong, Texas, and Australia. Established in 2013, the company specializes in the research and manufacturing of innovative medicines to address unmet medical needs, particularly in oncology and metabolic diseases. Utilizing advanced technology platforms such as deuterium and PROTAC, Hinova develops both Best-in-class and First-in-class drugs. Its product pipeline includes the HC-1119 androgen receptor antagonist and HC-1102 androgen receptor inhibitors, which target advanced prostate cancer and breast cancer. The company's commitment lies in providing safe, effective, and affordable treatments while retaining global rights and interests in its drug portfolio.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.